search
Back to results

A Randomized Controlled Trial:Treatments on Infundibular Ventricular Septal Defect

Primary Purpose

Heart Septal Defects, Ventricular, Double Outlet Right Ventricle, Noncommitted VSD, Double Outlet Right Ventricle, Subaortic VSD

Status
Completed
Phase
Not Applicable
Locations
China
Study Type
Interventional
Intervention
TEE-guided perventricular device closure without CBP
Surgery repair with CBP
Sponsored by
Bentong Yu
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Heart Septal Defects, Ventricular focused on measuring Infundibular Ventricular Septal Defect, occlusion, TEE-guided, asymmetric occluder, surgical repair

Eligibility Criteria

7 Days - 70 Years (Child, Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

(1) patients with single IVSD indicated by TTE,without concomitant cardiac malformation, serious arrhythmia or other important non-cardiac diseases;(2) patients whose ventricular septal defects from aortic residual < 3 mm, preoperative without aortic regurgitation or only mild reflux, defect size ≤10 mm;

Exclusion Criteria:

(1) defect size > 10 mm in diameter; (2) Preoperative with above moderate aortic valve prolapse (or) closed incompletely; (3) Eisenmenger syndrome caused by pulmonary hypertension,(4)decide temporarily to change method before surgery;(5) not signed informed consent application

Sites / Locations

  • Surgery Building of 1st Affiliated Hospital of Nanchang University

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Experimental

Arm Label

TPDC group

SR group

Arm Description

Patients who matched inclusion criteria and randomly divided into TPDC group underwent the TEE-guided perventricular device closure without CBP. But of them,who underwent TPDC failure during the procedure would be dropped out of the trial.

Patients who matched inclusion criteria and randomly assigned into SR group underwent the surgery repair with CBP.

Outcomes

Primary Outcome Measures

Surgery success rate
Surgery success means that patients in both TPDC and SR group don't change their surgery type either undergo a repeat surgery.

Secondary Outcome Measures

Hospitalization costs
The hospitalization costs calculated from hospital admission to hospital discharge

Full Information

First Posted
January 29, 2015
Last Updated
February 6, 2015
Sponsor
Bentong Yu
Collaborators
The Third Affiliated Hospital of Nanchang University
search

1. Study Identification

Unique Protocol Identification Number
NCT02361008
Brief Title
A Randomized Controlled Trial:Treatments on Infundibular Ventricular Septal Defect
Official Title
TEE-guided Perventricular Device Closure Through Minithoracotomy vs Traditional Surgery Repair Via CBP in Treatment of Infundibular Ventricular Septal Defect:A Two-center Clinical Randomized Controlled Trial
Study Type
Interventional

2. Study Status

Record Verification Date
February 2015
Overall Recruitment Status
Completed
Study Start Date
December 2012 (undefined)
Primary Completion Date
December 2014 (Actual)
Study Completion Date
December 2014 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
Bentong Yu
Collaborators
The Third Affiliated Hospital of Nanchang University

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of this study is to investigate the security and validity of transesophageal echocardiography(TEE)-guided perventricular device closure(TPDC) through minithoracotomy in treatment of infundibular ventricular septal defect(IVSD) with asymmetric occluder.
Detailed Description
Ventricular septal defect(VSD) , which accounted for about 20% of all congenital heart defects (CHDs) , is among the most common congenital heart malformations,among which infundibular ventricular septal defects(IVSD) is the least common type(18%).Multiple names for IVSD are in use. They can also be labeled conal VSD, subpulmonary VSD, subarterial VSD, doubly committed VSD, intracristal VSD,or supracristal VSD. These multiple denominations are not attached to specifically different anatomic subtypes.At present, the main methods to treat the specific anatomic condition contain conventional surgical repair(SR) and transcatheter interventional closure. The former need extracorporeal circulation,thus the side effects of extracorporeal circulation are inevitable,such as on the central nervous system, respiratory system, urinary system, etc. Although the latter has the characteristics of minimally invasive, patients should be exposed in X-ray withstanding potential risk of radiation. On the other hand,there are limits with age for patients who underwent transcatheter closure because of small vessel size. Fully developed blood vessels are to reach a certain diameter, but children need be up to 3 years old or so. In addition,the aortic valve was easily injured by wire and atrioventricular block was reported.Since the surrounding structure is complicated and the defect is too high, device closure of an IVSD is difficult to succeed in transcatheter approach. Traditional repair via cardiopulmonary bypass(CBP) is widely used to treat this kind of diseases. Past decade,with the development of technology and society,TEE-guided surgical occlusion through minithoracotomy was used to treat CHDs in an increasing number of popularity,avoiding the inherent risks of cardiopulmonary bypass and radiation,etc. But it is rarely reported to treat IVSD by minimally invasive perventricular device closure without CBP.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Heart Septal Defects, Ventricular, Double Outlet Right Ventricle, Noncommitted VSD, Double Outlet Right Ventricle, Subaortic VSD, Double Outlet Right Ventricle, Subpulmonary VSD, Supracristal Ventricular Septal Defect
Keywords
Infundibular Ventricular Septal Defect, occlusion, TEE-guided, asymmetric occluder, surgical repair

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Care Provider
Allocation
Randomized
Enrollment
20121212 (Actual)

8. Arms, Groups, and Interventions

Arm Title
TPDC group
Arm Type
Experimental
Arm Description
Patients who matched inclusion criteria and randomly divided into TPDC group underwent the TEE-guided perventricular device closure without CBP. But of them,who underwent TPDC failure during the procedure would be dropped out of the trial.
Arm Title
SR group
Arm Type
Experimental
Arm Description
Patients who matched inclusion criteria and randomly assigned into SR group underwent the surgery repair with CBP.
Intervention Type
Device
Intervention Name(s)
TEE-guided perventricular device closure without CBP
Other Intervention Name(s)
TPDC
Intervention Description
Perventricular device closure through minithoracotomy under the TEE-guidance without CBP.The device is an eccentric occluder made by Shanghai Shape Memory Alloy Co.,Ltd in Shanghai,China
Intervention Type
Procedure
Intervention Name(s)
Surgery repair with CBP
Other Intervention Name(s)
SR
Intervention Description
Traditional surgery repair under the CBP.
Primary Outcome Measure Information:
Title
Surgery success rate
Description
Surgery success means that patients in both TPDC and SR group don't change their surgery type either undergo a repeat surgery.
Time Frame
two months
Secondary Outcome Measure Information:
Title
Hospitalization costs
Description
The hospitalization costs calculated from hospital admission to hospital discharge
Time Frame
1 months
Other Pre-specified Outcome Measures:
Title
Length of hospital stay (post-op)
Description
Length of hospital stay refers in particular to the post-op stay in hospital.
Time Frame
1 months
Title
Mean bleeding volume
Description
The mean bleeding volume only referred during the procedure
Time Frame
6 hours
Title
Volume of drainage
Description
The volume of drainage is calculated from being moved off operating table to being pulled out drainage tube.
Time Frame
1 weeks
Title
Procedure time
Description
The procedure time is from skin cut to skin suture
Time Frame
6 hours

10. Eligibility

Sex
All
Minimum Age & Unit of Time
7 Days
Maximum Age & Unit of Time
70 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: (1) patients with single IVSD indicated by TTE,without concomitant cardiac malformation, serious arrhythmia or other important non-cardiac diseases;(2) patients whose ventricular septal defects from aortic residual < 3 mm, preoperative without aortic regurgitation or only mild reflux, defect size ≤10 mm; Exclusion Criteria: (1) defect size > 10 mm in diameter; (2) Preoperative with above moderate aortic valve prolapse (or) closed incompletely; (3) Eisenmenger syndrome caused by pulmonary hypertension,(4)decide temporarily to change method before surgery;(5) not signed informed consent application
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Bentong Yu, MD
Organizational Affiliation
1st Affiliaed Hospital of Nanchang University
Official's Role
Study Director
Facility Information:
Facility Name
Surgery Building of 1st Affiliated Hospital of Nanchang University
City
Nanchang
State/Province
Jiangxi
ZIP/Postal Code
330006
Country
China

12. IPD Sharing Statement

Learn more about this trial

A Randomized Controlled Trial:Treatments on Infundibular Ventricular Septal Defect

We'll reach out to this number within 24 hrs